|【英語タイトル】Antibe Therapeutics Inc (ATE) - Financial and Strategic SWOT Analysis Review|
Antibe Therapeutics Inc (Antibe) is a biotech company that designs and develops drug candidates for chronic pain and inflammation; and regenerative medicine. The company discovers and commercializes novel drugs, biologics and medical devices. It offers lead compound ATB-346, a naproxen derivative for osteoarthritis, rheumatoid arthritis and ankylosing spondylitis; ATB-352 for gout, dental pain, post-surgical pain, and ATB-340 for chronic prevention of cardiovascular disease and cancer chemoprevention. Antibe also offers regenerative medical devices such as CGX-227, CGX-443 and CGX-276 which are indicated for oral and maxillofacial surgery. The company markets its products in Canada and abroad. Antibe is headquartered in Toronto, Ontario, Canada.
Antibe Therapeutics Inc Key Recent Developments
Nov 30,2018: Antibe Therapeutics to present at the 11th Annual LD Micro Main Event on December 4, 2018
Nov 23,2018: Antibe Therapeutics reports Q2 2019 interim financial and operating results
Oct 22,2018: Antibe Therapeutics establishes business development Advisory Board
Oct 10,2018: Antibe Therapeutics Receives Approval to Initiate Part One of Phase 2B Dose-Ranging, Efficacy Study for ATB-346
Oct 03,2018: Antibe Therapeutics Announces Grant of Restricted Share Units
This comprehensive SWOT profile of Antibe Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Antibe Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Antibe Therapeutics Inc – Key Information
Antibe Therapeutics Inc – Overview
Antibe Therapeutics Inc – Key Employees
Antibe Therapeutics Inc – Key Employee Biographies
Antibe Therapeutics Inc – Key Operational Heads
Antibe Therapeutics Inc – Major Products and Services
Antibe Therapeutics Inc – History
Antibe Therapeutics Inc – Company Statement
Antibe Therapeutics Inc – Locations And Subsidiaries
Antibe Therapeutics Inc – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
Antibe Therapeutics Inc – Business Description
Antibe Therapeutics Inc – Corporate Strategy
Antibe Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Antibe Therapeutics Inc – Strengths
Antibe Therapeutics Inc – Weaknesses
Antibe Therapeutics Inc – Opportunities
Antibe Therapeutics Inc – Threats
Antibe Therapeutics Inc – Key Competitors
Section 3 – Company Financial Performance Charts
Antibe Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Antibe Therapeutics Inc, Key Information
Antibe Therapeutics Inc, Key Ratios
Antibe Therapeutics Inc, Share Data
Antibe Therapeutics Inc, Major Products and Services
Antibe Therapeutics Inc, History
Antibe Therapeutics Inc, Key Employees
Antibe Therapeutics Inc, Key Employee Biographies
Antibe Therapeutics Inc, Key Operational Heads
Antibe Therapeutics Inc, Other Locations
Antibe Therapeutics Inc, Subsidiaries
Antibe Therapeutics Inc, Key Manufacturing facilities
Antibe Therapeutics Inc, Key Competitors
Antibe Therapeutics Inc, SWOT Analysis
Antibe Therapeutics Inc, Ratios based on current share price
Antibe Therapeutics Inc, Annual Ratios
Antibe Therapeutics Inc, Interim Ratios
Capital Market Ratios
List of Figures
Antibe Therapeutics Inc, Performance Chart
Antibe Therapeutics Inc, Ratio Charts
|★調査レポート[Antibe Therapeutics Inc (ATE)：企業の財務・戦略的SWOT分析]
|★調査レポート[Antibe Therapeutics Inc (ATE)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせ